Gain Therapeutics to Attend the 2025 Maxim Growth Summit
BETHESDA, Md., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology...
Clinical Trial
Cellectis Hosts R&D Day Today Showcasing Pipeline Progress and Long-Term Value Drivers
Event features full Phase 1 data and pivotal Phase 2 strategy for lasme-cel (UCART22) in r/r B-ALL NEW YORK, Oct....
Foghorn Therapeutics Announces Significant Progress for Selective ARID1B Degrader at the 8th Annual TPD and Induced Proximity Summit
Foghorn to host a virtual investor event on updates for its Selective ARID1B, Selective CBP and Selective EP300 degrader programs...
MOEA DoIT Showcases 65 Cutting-Edge Technologies at TIE
Unveiling AI Clothing Sorting System and New Equipment for Depression Treatment TAIPEI, Oct. 16, 2025 /PRNewswire/ -- The Department of...
C-Path’s Disease Modeling Coalition Begins Global Pediatric IBD Work from European Hub
AMSTERDAM, Oct. 16, 2025 /PRNewswire/ -- Critical Path Institute® (C-Path) today announced the official launch of the Critical Path Disease...
The Lustgarten Foundation Gathered Nation’s Foremost Pancreatic Cancer Experts for Annual Scientific Advisory Board Meeting
COLD SPRING HARBOR, N.Y., Oct. 15, 2025 /PRNewswire/ -- The Lustgarten Foundation, the world's largest private funder of pancreatic cancer...
Introducing ICON Strategic Solutions FSP Services: How This Model Supports Sponsors in Korea, Upcoming Webinar Hosted by Xtalks
In this free webinar, gain insight into how ICON Strategic Solutions (ISS) delivers Functional Service Provider (FSP) services that outperform...
Hemostemix Adds the Treatment of Refractory Angina to Its Phase 1 Basket Protocol
Calgary, Alberta--(Newsfile Corp. - October 15, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's...
AccessHope Launches New Service to Help More Cancer Patients Enroll in Clinical Trials
Expands support and access by matching eligible patients to trials and guiding them through enrollment DUARTE, Calif., Oct. 15, 2025 /PRNewswire/...
TriNetX Becomes the Most Cited Real-World Data Source in Peer-Reviewed Research
With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces competitors and fuels high-impact science published in top...
Avantor® and BlueWhale Bio Partner to Accelerate CAR-T Manufacturing with Breakthrough Cell Activation and Expansion Technology
RADNOR, Pa. and PHILADELPHIA, Oct. 15, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to...
NanoViricides Dual Track Clinical Strategy Explained by a Research Report – Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage for MPox and also for Acute Respiratory Infections of All Viruses
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that an analyst...
Novo Nordisk and Omeros announce asset purchase and license agreement for Omeros’ clinical-stage MASP-3 inhibitor zaltenibart (OMS906)
Zaltenibart has best-in-class potential across multiple rare blood and kidney disorders and will enhance Novo Nordisk’s Rare Disease portfolioOmeros is...
MMI Enrolls First Patient in Landmark U.S. Clinical Study Advancing Robotic Microsurgery
PRECISE study to generate pivotal clinical data for the Symani® Surgical System in free tissue transfer and lymphatic surgical repairJACKSONVILLE,...
Akari Therapeutics Announces $2.5 Million Registered Direct Offering
BOSTON and LONDON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX) (the “Company”), an oncology biotechnology company...
Aignostics Launches AI-Powered Application for Tumor Microenvironment Profiling
Atlas H&E-TME delivers robust analyses at single-cell resolution in hours BERLIN and NEW YORK, Oct. 15, 2025 /PRNewswire/ -- Following...
Luminopia Recognized on Fast Company’s Next Big Things in Tech List
The annual list honors groundbreaking advancements redefining the way we work and live CAMBRIDGE, Mass., Oct. 14, 2025 /PRNewswire/ --...
Carolina Molecular Selected as Certified Service Provider for CS Genetics’ Single-Cell Sequencing Platform
Collaboration expands access to scalable, cost-efficient single-cell RNA sequencing for translational and clinical research MORRISVILLE, N.C. and SAN DIEGO, Oct....
OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care
BELLEVUE, Wash., Oct. 14, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH) today announced that it has executed a definitive agreement...
Sibel Health Secures Additional Series C Extension Funding to $39 million from Key Strategic Investors and Announces New Board of Director Appointments
CHICAGO, Oct. 14, 2025 /PRNewswire/ -- Sibel Health, an award-winning digital health company, today announced the close of a Series...